Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Condition(s):Polycystic Ovary SyndromeLast Updated:October 14, 2020Recruiting
Hide Studies Not Open or Pending
Condition(s):Polycystic Ovary SyndromeLast Updated:October 14, 2020Recruiting
Condition(s):Transgender PersonsLast Updated:August 19, 2020Completed
Condition(s):HIV Infection; Vaginal Atrophy; Menopause; Menopause Related Conditions; Aging; Premature Aging; Atrophic Vaginitis; Dysbiosis; VaginitisLast Updated:December 16, 2020Recruiting
Condition(s):InfertilityLast Updated:February 7, 2019Recruiting
Condition(s):Diabetes Type 2; DementiaLast Updated:November 25, 2020Active, not recruiting
Condition(s):Estrogen Levels Among Breast Cancer PatientsLast Updated:May 21, 2019Completed
Condition(s):Fertility DisordersLast Updated:August 3, 2017Unknown status
Condition(s):Follicle Stimulating Hormone Glycosylation; Urinary FSH21/FSH24 Ratio; Estradiol EffectLast Updated:July 12, 2019Recruiting
Condition(s):Atrophic Vaginitis; Breast CancerLast Updated:October 19, 2020Active, not recruiting
Condition(s):Suppression of OvulationLast Updated:August 15, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.